Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPG20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RNFT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRCA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC38A6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBMS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SKAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP1S2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF117 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
APAF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RECQL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PELI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
H2AFV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNLT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on